Greg Young
0009-0000-6013-528X
Publication & Citation Trends
Publications
45 total
Abstract PS5-08-21: Prospective breast cancer clinical validation study of an ultrasensitive, tumor-informed, whole genome, circulating tumor DNA assay to detect molecular residual disease and predict recurrence of high-risk early breast cancer treated with standard (neo)adjuvant therapy; NSABP B-64
Cited by 0
Semantic Scholar
Abstract RF4-03: Evaluation of a whole-exome sequencing tumor-informed circulating tumor DNA MRD assay in patients with early triple-negative breast cancer (TNBC) receiving neoadjuvant chemotherapy (NAC) with or without atezolizumab: A prospective sub study of the NSABP-B59/GBG-96-GeparDouze Trial
Cited by 0
Semantic Scholar
Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α‐CORRECT Study
Cited by 5
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(7)
Colorectal Cancer Treatments and Studies
(4)
Genetic factors in colorectal cancer
(4)
Interprofessional Education and Collaboration
(3)
Genomics and Phylogenetic Studies
(2)
Affiliations
Baptist Hospital of Miami
Royal Women's Hospital
The University of Texas MD Anderson Cancer Center
Thomas Jefferson University
Pfizer (United States)